|
|
Cholesterol adrift on a lipid raft affects cancer progression
Mar 18, 2005, 23:06, Reviewed by: Dr.
|
|
The authors show that depletion of cholesterol by a cholesterol- lowering drug (simvastatin) induces death of prostate cancer cells.
|
By Journal of Clinical Investigation,
Michael Freeman and colleagues from Harvard Medical School examine whether the cholesterol content of lipid rafts plays a role in prostate cancer. Lipid rafts are small regions in the membranes of cells that contain high levels of cholesterol.
The authors show that depletion of cholesterol by a cholesterol- lowering drug (simvastatin) induces death of prostate cancer cells. Elevating cholesterol content had the opposite effect, promoting tumor growth and decreasing death of the cancerous cells.
Thus, the cholesterol content of lipid rafts in cell membranes may mediate tumor survival and may be a potential target involved in tumor progression. 
- TITLE: Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts; April 1 print edition of the Journal of Clinical Investigation
PDF of this article
AUTHOR CONTACT:
Michael Freeman
Children's Hospital Boston, Boston, Massachusetts, United States
Phone: 617-355-6054; Fax: 617-730-0238; E-mail: [email protected]
|
For any corrections of factual information, to contact the editors or to send
any medical news or health news press releases, use
feedback form
Top of Page
|
|
|
|
